Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page
- Check4 days agoChange DetectedMinor site version update from v3.4.0 to v3.4.1 with no visible changes to the study details page, eligibility criteria, or results; to avoid alerts from small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check26 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4; this change does not affect study content or user experience. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedExpanded Locations section with numerous new sites across the US, Argentina, Australia, and many other countries.SummaryDifference3%

- Check76 days agoChange DetectedAdded clarifying sentences about how publications are provided and automatically filled from PubMed, and updated the Revision to v3.3.2. The deletions remove older wording describing the PubMed-derived list and the previous revision number.SummaryDifference0.1%

- Check84 days agoChange DetectedRemoved the government funding/operating status notice from the page, which previously informed users about potential delays and site status. This change does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check105 days agoChange DetectedThe screenshots show no substantive updates to the study record beyond minor formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.